AU6825198A - Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid - Google Patents
Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acidInfo
- Publication number
- AU6825198A AU6825198A AU68251/98A AU6825198A AU6825198A AU 6825198 A AU6825198 A AU 6825198A AU 68251/98 A AU68251/98 A AU 68251/98A AU 6825198 A AU6825198 A AU 6825198A AU 6825198 A AU6825198 A AU 6825198A
- Authority
- AU
- Australia
- Prior art keywords
- compound
- crystalline hydrated
- sodium salt
- hydrated form
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
GB9704498 | 1997-03-05 | ||
PCT/EP1998/001146 WO1998039327A1 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6825198A true AU6825198A (en) | 1998-09-22 |
Family
ID=10808697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU68251/98A Abandoned AU6825198A (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP0966463A1 (es) |
JP (1) | JP2001513796A (es) |
KR (1) | KR20000075907A (es) |
CN (1) | CN1249750A (es) |
AP (1) | AP9901637A0 (es) |
AR (1) | AR011178A1 (es) |
AU (1) | AU6825198A (es) |
BG (1) | BG103779A (es) |
BR (1) | BR9808305A (es) |
CA (1) | CA2282851A1 (es) |
CO (1) | CO4940415A1 (es) |
EA (1) | EA199900710A1 (es) |
EE (1) | EE9900387A (es) |
GB (1) | GB9704498D0 (es) |
HR (1) | HRP980114A2 (es) |
HU (1) | HUP0002109A2 (es) |
ID (1) | ID24207A (es) |
IL (1) | IL131489A0 (es) |
IS (1) | IS5166A (es) |
NO (1) | NO994303L (es) |
NZ (1) | NZ337315A (es) |
OA (1) | OA11154A (es) |
PE (1) | PE51399A1 (es) |
PL (1) | PL335652A1 (es) |
SK (1) | SK119699A3 (es) |
TR (1) | TR199902117T2 (es) |
WO (1) | WO1998039327A1 (es) |
YU (1) | YU43499A (es) |
ZA (1) | ZA981791B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
BR112019026449A2 (pt) | 2017-06-12 | 2020-08-11 | Glytech Llc. | composição e método para tratamento de depressão e psicose em humanos |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 EE EEP199900387A patent/EE9900387A/xx unknown
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Application Discontinuation
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Application Discontinuation
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HRP980114A2 (en) | 1998-12-31 |
KR20000075907A (ko) | 2000-12-26 |
IL131489A0 (en) | 2001-01-28 |
CO4940415A1 (es) | 2000-07-24 |
TR199902117T2 (xx) | 2000-03-21 |
WO1998039327A1 (en) | 1998-09-11 |
NO994303L (no) | 1999-11-03 |
BR9808305A (pt) | 2000-05-16 |
OA11154A (en) | 2003-04-16 |
EP0966463A1 (en) | 1999-12-29 |
NO994303D0 (no) | 1999-09-03 |
EA199900710A1 (ru) | 2000-04-24 |
PE51399A1 (es) | 1999-06-07 |
EE9900387A (et) | 2000-04-17 |
SK119699A3 (en) | 2000-05-16 |
PL335652A1 (en) | 2000-05-08 |
HUP0002109A2 (hu) | 2001-04-28 |
CA2282851A1 (en) | 1998-09-11 |
IS5166A (is) | 1999-08-27 |
CN1249750A (zh) | 2000-04-05 |
AR011178A1 (es) | 2000-08-02 |
AP9901637A0 (en) | 1999-09-30 |
ID24207A (id) | 2000-07-13 |
GB9704498D0 (en) | 1997-04-23 |
YU43499A (sh) | 2000-12-28 |
NZ337315A (en) | 2001-02-23 |
JP2001513796A (ja) | 2001-09-04 |
ZA981791B (en) | 1999-09-03 |
BG103779A (en) | 2000-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP480A (en) | 3-Substituted indole 2-carboxylic acid derivatives. | |
EP0699186A1 (en) | Indole derivatives as antagonists of excitatory amino acids | |
JPH09503770A (ja) | Nmdaアンタゴニストとしてのインドール誘導体 | |
WO2013004190A1 (zh) | 胺基丙二醇类衍生物、其制备方法和其药物组合物与用途 | |
AU6825198A (en) | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid | |
AU731394B2 (en) | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist | |
TWI399374B (zh) | 新穎晶體形式及製備方法以及其醫藥組合物 | |
CA2393303C (en) | Meglumine salt of a specific quinolinecarboxylic acid compound | |
CZ314799A3 (cs) | Krystalická hydratovaná sodná sůl kyseliny (E)-4,6-dichlor-3-(2-oxo-l-fenylpyrrolidin-3- ylidenmethyl)-lH-indol-2-karboxylové | |
CN113788835A (zh) | 一种含吗啉和喹啉环的三唑并四嗪类化合物及其制备方法和应用 | |
KR20030069228A (ko) | 나트륨-수소 교환물질 1형 억제제의 에탄올레이트 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |